speb/financial-data huggingface dataset:
IMVT balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 72000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 72000.00
IMVT balance_sheet (annual, 2026-03-31) — Capital Stock: 20000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 20000.00
IMVT balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 902110000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 902110000.00
IMVT balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 902110000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 902110000.00
IMVT cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Financing Activities: 595756000.00
IMVT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 3640000.00
IMVT cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Investing Activities: -8000.00
IMVT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -8000.00
IMVT cash_flow (annual, 2026-03-31) — Cash Flow From Continuing Operating Activities: -407310000.00
IMVT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -95059000.00
IMVT cash_flow (annual, 2026-03-31) — Change In Account Payable: -10252000.00
IMVT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -1349000.00
IMVT cash_flow (annual, 2026-03-31) — Change In Accrued Expense: 45000000.00
IMVT cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 39289000.00
IMVT cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 69000.00
IMVT cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 1301000.00
IMVT cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -99000.00
IMVT cash_flow (annual, 2026-03-31) — Change In Payable: -10350000.00
IMVT cash_flow (quarterly, 2026-03-31) — Change In Payable: -1447000.00
IMVT cash_flow (annual, 2026-03-31) — Change In Payables And Accrued Expense: 34650000.00
IMVT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 37842000.00
IMVT cash_flow (annual, 2026-03-31) — Change In Prepaid Assets: 8844000.00
IMVT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 4313000.00
IMVT cash_flow (annual, 2026-03-31) — Change In Receivables: -1400000.00
IMVT cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1823000.00
IMVT cash_flow (annual, 2026-03-31) — Change In Working Capital: 42064000.00
IMVT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 41534000.00
IMVT cash_flow (annual, 2026-03-31) — Changes In Account Receivables: 986000.00
IMVT cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 563000.00
IMVT cash_flow (annual, 2026-03-31) — Changes In Cash: 188438000.00
IMVT cash_flow (quarterly, 2026-03-31) — Changes In Cash: -91427000.00
IMVT balance_sheet (annual, 2026-03-31) — Common Stock: 20000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Common Stock: 20000.00
IMVT balance_sheet (annual, 2026-03-31) — Common Stock Equity: 852592000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 852592000.00
IMVT cash_flow (annual, 2026-03-31) — Common Stock Issuance: 544194000.00
IMVT cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
IMVT balance_sheet (annual, 2026-03-31) — Current Accrued Expenses: 79867000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 79867000.00
IMVT balance_sheet (annual, 2026-03-31) — Current Assets: 948819000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Current Assets: 948819000.00
IMVT balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 72000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 72000.00
IMVT balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 72000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 72000.00
IMVT balance_sheet (annual, 2026-03-31) — Current Liabilities: 104422000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 104422000.00
IMVT cash_flow (annual, 2026-03-31) — Depreciation: 409000.00
IMVT cash_flow (quarterly, 2026-03-31) — Depreciation: 96000.00
IMVT cash_flow (annual, 2026-03-31) — Depreciation Amortization Depletion: 409000.00
IMVT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 96000.00
IMVT cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 409000.00
IMVT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 96000.00
IMVT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 203709320.00
IMVT income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.73
IMVT income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -505606000.00
IMVT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -147856000.00
IMVT balance_sheet (annual, 2026-03-31) — Dueto Related Parties Current: 175000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Dueto Related Parties Current: 175000.00
IMVT income_statement (annual, 2026-03-31) — EBIT: -532902000.00
IMVT income_statement (quarterly, 2026-03-31) — EBIT: -159554000.00
IMVT income_statement (annual, 2026-03-31) — EBITDA: -532493000.00
IMVT income_statement (quarterly, 2026-03-31) — EBITDA: -159458000.00
IMVT cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: -299000.00
IMVT cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -988000.00
IMVT cash_flow (annual, 2026-03-31) — End Cash Position: 902110000.00
IMVT cash_flow (quarterly, 2026-03-31) — End Cash Position: 902110000.00
IMVT cash_flow (annual, 2026-03-31) — Financing Cash Flow: 595756000.00
IMVT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 3640000.00
IMVT cash_flow (annual, 2026-03-31) — Free Cash Flow: -407318000.00
IMVT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -95067000.00
IMVT balance_sheet (annual, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 730000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 730000.00
IMVT income_statement (annual, 2026-03-31) — General And Administrative Expense: 76242000.00
IMVT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 17267000.00
IMVT balance_sheet (annual, 2026-03-31) — Gross PPE: 515000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 515000.00
IMVT cash_flow (annual, 2026-03-31) — Income Tax Paid Supplemental Data: 2386000.00
IMVT cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: -51000.00
IMVT income_statement (annual, 2026-03-31) — Interest Income: 25330000.00
IMVT income_statement (quarterly, 2026-03-31) — Interest Income: 8056000.00
IMVT income_statement (annual, 2026-03-31) — Interest Income Non Operating: 25330000.00
IMVT income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 8056000.00
IMVT balance_sheet (annual, 2026-03-31) — Invested Capital: 852592000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 852592000.00
IMVT cash_flow (annual, 2026-03-31) — Investing Cash Flow: -8000.00
IMVT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -8000.00
IMVT cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 544194000.00
IMVT cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
IMVT cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 544194000.00
IMVT cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
IMVT income_statement (annual, 2026-03-31) — Net Income: -505606000.00
IMVT income_statement (quarterly, 2026-03-31) — Net Income: -147856000.00
IMVT income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -505606000.00
IMVT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -147856000.00
IMVT income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -505606000.00
IMVT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -147856000.00
IMVT income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -505606000.00
IMVT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -147856000.00
IMVT income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -505606000.00
IMVT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -147856000.00
IMVT cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -505606000.00
IMVT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -147856000.00
IMVT income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -505606000.00
IMVT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -147856000.00
IMVT income_statement (annual, 2026-03-31) — Net Interest Income: 25330000.00
IMVT income_statement (quarterly, 2026-03-31) — Net Interest Income: 8056000.00
IMVT income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 25330000.00
IMVT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 8056000.00
IMVT cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -504000.00
IMVT cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 82000.00
IMVT balance_sheet (annual, 2026-03-31) — Net PPE: 515000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Net PPE: 515000.00
IMVT cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -8000.00
IMVT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -8000.00
IMVT balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 852592000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 852592000.00
IMVT income_statement (annual, 2026-03-31) — Normalized EBITDA: -532493000.00
IMVT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -159458000.00
IMVT income_statement (annual, 2026-03-31) — Normalized Income: -505606000.00
IMVT income_statement (quarterly, 2026-03-31) — Normalized Income: -147856000.00
IMVT cash_flow (annual, 2026-03-31) — Operating Cash Flow: -407310000.00
IMVT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -95059000.00
IMVT income_statement (annual, 2026-03-31) — Operating Income: -532902000.00
IMVT income_statement (quarterly, 2026-03-31) — Operating Income: -159554000.00
IMVT income_statement (annual, 2026-03-31) — Operating Revenue: 0.00
IMVT income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
IMVT balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 203940353.00
IMVT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 203940353.00
IMVT balance_sheet (annual, 2026-03-31) — Other Current Assets: 42763000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 42763000.00
IMVT balance_sheet (annual, 2026-03-31) — Other Equity Adjustments: 730000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 730000.00
IMVT income_statement (annual, 2026-03-31) — Other Gand A: 76242000.00
IMVT income_statement (quarterly, 2026-03-31) — Other Gand A: 17267000.00
IMVT income_statement (annual, 2026-03-31) — Other Income Expense: 2181000.00
IMVT income_statement (quarterly, 2026-03-31) — Other Income Expense: 798000.00
IMVT cash_flow (annual, 2026-03-31) — Other Non Cash Items: 99000.00
IMVT cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 26000.00
IMVT balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 7680000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 7680000.00
IMVT income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 2181000.00
IMVT income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 798000.00
IMVT balance_sheet (annual, 2026-03-31) — Other Properties: 515000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Other Properties: 515000.00
IMVT balance_sheet (annual, 2026-03-31) — Payables: 7716000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Payables: 7716000.00
IMVT balance_sheet (annual, 2026-03-31) — Payables And Accrued Expenses: 87583000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 87583000.00
IMVT balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 16767000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 16767000.00
IMVT balance_sheet (annual, 2026-03-31) — Preferred Shares Number: 10000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Preferred Shares Number: 10000.00
IMVT balance_sheet (annual, 2026-03-31) — Preferred Stock: 0.00
IMVT balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
IMVT income_statement (annual, 2026-03-31) — Pretax Income: -505391000.00
IMVT income_statement (quarterly, 2026-03-31) — Pretax Income: -150700000.00
IMVT cash_flow (annual, 2026-03-31) — Proceeds From Stock Option Exercised: 52066000.00
IMVT cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 3558000.00
IMVT cash_flow (annual, 2026-03-31) — Purchase Of PPE: -8000.00
IMVT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -8000.00
IMVT balance_sheet (annual, 2026-03-31) — Receivables: 3946000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Receivables: 3946000.00
IMVT income_statement (annual, 2026-03-31) — Reconciled Depreciation: 409000.00
IMVT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 96000.00
IMVT income_statement (annual, 2026-03-31) — Research And Development: 456660000.00
IMVT income_statement (quarterly, 2026-03-31) — Research And Development: 142287000.00
IMVT income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 0.00
IMVT balance_sheet (annual, 2026-03-31) — Retained Earnings: -1745129000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -1745129000.00
IMVT income_statement (annual, 2026-03-31) — Selling General And Administration: 76242000.00
IMVT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 17267000.00
IMVT balance_sheet (annual, 2026-03-31) — Share Issued: 203940353.00
IMVT balance_sheet (quarterly, 2026-03-31) — Share Issued: 203940353.00
IMVT income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
IMVT cash_flow (annual, 2026-03-31) — Stock Based Compensation: 55724000.00
IMVT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 11141000.00
IMVT balance_sheet (annual, 2026-03-31) — Stockholders Equity: 852592000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 852592000.00
IMVT balance_sheet (annual, 2026-03-31) — Tangible Book Value: 852592000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 852592000.00
IMVT income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
IMVT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
IMVT income_statement (annual, 2026-03-31) — Tax Provision: 215000.00
IMVT income_statement (quarterly, 2026-03-31) — Tax Provision: -2844000.00
IMVT income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
IMVT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.02
IMVT balance_sheet (annual, 2026-03-31) — Taxes Receivable: 2813000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 2813000.00
IMVT balance_sheet (annual, 2026-03-31) — Total Assets: 957014000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Total Assets: 957014000.00
IMVT balance_sheet (annual, 2026-03-31) — Total Capitalization: 852592000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 852592000.00
IMVT balance_sheet (annual, 2026-03-31) — Total Debt: 72000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Total Debt: 72000.00
IMVT balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 852592000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 852592000.00
IMVT income_statement (annual, 2026-03-31) — Total Expenses: 532902000.00
IMVT income_statement (quarterly, 2026-03-31) — Total Expenses: 159554000.00
IMVT balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 104422000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 104422000.00
IMVT balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 8195000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 8195000.00
IMVT balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IMVT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
IMVT income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
IMVT income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
IMVT balance_sheet (annual, 2026-03-31) — Working Capital: 844397000.00
IMVT balance_sheet (quarterly, 2026-03-31) — Working Capital: 844397000.00
IMXI balance_sheet (annual, 2021-12-31) — Cash Financial: 132474000.00
IMXI balance_sheet (annual, 2021-12-31) — Current Debt: 3882000.00
IMXI cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
IMXI balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 2032000.00
IMXI balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 3882000.00
IMXI income_statement (annual, 2021-12-31) — Other Operating Expenses: -3133000.00
IMXI income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 30334000.00
IMXI cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
IMXI income_statement (annual, 2022-12-31) — +Operating Expense: 96088000.00
IMXI income_statement (annual, 2022-12-31) — +Total Revenue: 546805000.00
IMXI balance_sheet (annual, 2022-12-31) — Accounts Payable: 25686000.00
IMXI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 129808000.00
IMXI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -33654000.00
IMXI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 70210000.00
IMXI balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -2555000.00
IMXI income_statement (annual, 2022-12-31) — Basic Average Shares: 37733047.00
IMXI income_statement (annual, 2022-12-31) — Basic EPS: 1.52
IMXI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 132474000.00
IMXI balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 565000.00
IMXI cash_flow (annual, 2022-12-31) — Capital Expenditure: -12173000.00
IMXI balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 28530000.00
IMXI balance_sheet (annual, 2022-12-31) — Capital Stock: 4000.00
IMXI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 149493000.00
IMXI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 149493000.00
IMXI balance_sheet (annual, 2022-12-31) — Cash Financial: 149493000.00
IMXI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 14058000.00
IMXI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -12529000.00
IMXI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 15174000.00
IMXI cash_flow (annual, 2022-12-31) — Change In Account Payable: -1042000.00
IMXI cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 594000.00
IMXI cash_flow (annual, 2022-12-31) — Change In Payable: 18692000.00
IMXI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 18692000.00
IMXI cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -36363000.00
IMXI cash_flow (annual, 2022-12-31) — Change In Receivables: -48628000.00
IMXI cash_flow (annual, 2022-12-31) — Change In Working Capital: -65705000.00
IMXI cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -48628000.00
IMXI cash_flow (annual, 2022-12-31) — Changes In Cash: 16703000.00
IMXI balance_sheet (annual, 2022-12-31) — Common Stock: 4000.00
IMXI balance_sheet (annual, 2022-12-31) — Common Stock Equity: 149906000.00
IMXI cash_flow (annual, 2022-12-31) — Common Stock Payments: -53734000.00
IMXI balance_sheet (annual, 2022-12-31) — Construction In Progress: 0.00
IMXI income_statement (annual, 2022-12-31) — Cost Of Revenue: 364804000.00
IMXI balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 10594000.00
IMXI balance_sheet (annual, 2022-12-31) — Current Assets: 382436000.00
IMXI balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 5258000.00
IMXI balance_sheet (annual, 2022-12-31) — Current Debt: 4975000.00
IMXI balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 10233000.00
IMXI balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 4212000.00
IMXI balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 4212000.00
IMXI balance_sheet (annual, 2022-12-31) — Current Liabilities: 184767000.00
IMXI cash_flow (annual, 2022-12-31) — Deferred Income Tax: -503000.00
IMXI cash_flow (annual, 2022-12-31) — Deferred Tax: -503000.00
IMXI cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 9470000.00
IMXI income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 9470000.00
IMXI cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 9470000.00
IMXI income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 9470000.00
IMXI income_statement (annual, 2022-12-31) — Diluted Average Shares: 38625390.00
IMXI income_statement (annual, 2022-12-31) — Diluted EPS: 1.48
IMXI income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 57331000.00
IMXI income_statement (annual, 2022-12-31) — EBIT: 82908000.00
IMXI income_statement (annual, 2022-12-31) — EBITDA: 92378000.00
IMXI cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 316000.00
IMXI cash_flow (annual, 2022-12-31) — End Cash Position: 149493000.00
IMXI cash_flow (annual, 2022-12-31) — Financing Cash Flow: 14058000.00
IMXI cash_flow (annual, 2022-12-31) — Free Cash Flow: 3001000.00
IMXI cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 788000.00
IMXI balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -142000.00
IMXI income_statement (annual, 2022-12-31) — General And Administrative Expense: 86618000.00
IMXI balance_sheet (annual, 2022-12-31) — Goodwill: 49774000.00
IMXI balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 69600000.00
IMXI balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 132363000.00
IMXI balance_sheet (annual, 2022-12-31) — Gross PPE: 86582000.00
IMXI income_statement (annual, 2022-12-31) — Gross Profit: 182001000.00
IMXI cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 24265000.00
IMXI income_statement (annual, 2022-12-31) — Interest Expense: 5629000.00
IMXI income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 5629000.00
IMXI cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 4625000.00
IMXI balance_sheet (annual, 2022-12-31) — Invested Capital: 305116000.00
IMXI cash_flow (annual, 2022-12-31) — Investing Cash Flow: -12529000.00
IMXI cash_flow (annual, 2022-12-31) — Issuance Of Debt: 76000000.00
IMXI balance_sheet (annual, 2022-12-31) — Land And Improvements: 36000.00
IMXI balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 23272000.00
IMXI balance_sheet (annual, 2022-12-31) — Long Term Debt: 150235000.00
IMXI balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 173507000.00
IMXI cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 76000000.00
IMXI cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -4375000.00
IMXI balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 55613000.00
IMXI cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -356000.00
IMXI cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -53734000.00
IMXI balance_sheet (annual, 2022-12-31) — Net Debt: 5717000.00
IMXI income_statement (annual, 2022-12-31) — Net Income: 57331000.00
IMXI income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 57331000.00
IMXI income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 57331000.00
IMXI income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 57331000.00
IMXI income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 57331000.00
IMXI cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 57331000.00
IMXI income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 57331000.00
IMXI income_statement (annual, 2022-12-31) — Net Interest Income: -5629000.00
IMXI cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 71625000.00
IMXI cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 71625000.00
IMXI income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -5629000.00
IMXI cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -5493000.00
IMXI balance_sheet (annual, 2022-12-31) — Net PPE: 52928000.00
IMXI cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -12173000.00
IMXI cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 76000000.00
IMXI balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 80306000.00
IMXI balance_sheet (annual, 2022-12-31) — Non Current Accounts Receivable: 1392000.00
IMXI balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 1578000.00
IMXI balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 3892000.00
IMXI balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 3892000.00
IMXI balance_sheet (annual, 2022-12-31) — Non Current Prepaid Assets: 1062000.00
IMXI income_statement (annual, 2022-12-31) — Normalized EBITDA: 95383000.00
IMXI income_statement (annual, 2022-12-31) — Normalized Income: 59560320.45
IMXI cash_flow (annual, 2022-12-31) — Operating Cash Flow: 15174000.00
IMXI cash_flow (annual, 2022-12-31) — Operating Gains Losses: 788000.00
IMXI income_statement (annual, 2022-12-31) — Operating Income: 85913000.00
IMXI income_statement (annual, 2022-12-31) — Operating Revenue: 542082000.00
IMXI balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 36630970.00
IMXI balance_sheet (annual, 2022-12-31) — Other Current Assets: 4730000.00
IMXI balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 4975000.00
IMXI balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1321000.00
IMXI balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -142000.00
IMXI income_statement (annual, 2022-12-31) — Other Gand A: 34394000.00
IMXI income_statement (annual, 2022-12-31) — Other Income Expense: -3005000.00
IMXI balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 19826000.00
IMXI cash_flow (annual, 2022-12-31) — Other Non Cash Items: 4103000.00
IMXI balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 4654000.00
IMXI income_statement (annual, 2022-12-31) — Other Operating Expenses: -4723000.00
IMXI balance_sheet (annual, 2022-12-31) — Other Payable: 131392000.00
IMXI balance_sheet (annual, 2022-12-31) — Other Properties: 30368000.00
IMXI balance_sheet (annual, 2022-12-31) — Other Receivables: 1311000.00
IMXI balance_sheet (annual, 2022-12-31) — Payables: 158407000.00
IMXI balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 169001000.00
IMXI balance_sheet (annual, 2022-12-31) — Prepaid Assets: 97094000.00
IMXI income_statement (annual, 2022-12-31) — Pretax Income: 77279000.00
IMXI cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 1660000.00
IMXI balance_sheet (annual, 2022-12-31) — Properties: 0.00
IMXI cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 2572000.00
IMXI cash_flow (annual, 2022-12-31) — Purchase Of Business: -356000.00
IMXI cash_flow (annual, 2022-12-31) — Purchase Of PPE: -12173000.00
IMXI balance_sheet (annual, 2022-12-31) — Receivables: 131119000.00
IMXI income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 364804000.00
IMXI income_statement (annual, 2022-12-31) — Reconciled Depreciation: 9470000.00
IMXI cash_flow (annual, 2022-12-31) — Repayment Of Debt: -4375000.00
IMXI cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -53734000.00
IMXI income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 3005000.00
IMXI balance_sheet (annual, 2022-12-31) — Retained Earnings: 139134000.00
IMXI income_statement (annual, 2022-12-31) — Salaries And Wages: 52224000.00
IMXI income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 34394000.00
IMXI income_statement (annual, 2022-12-31) — Selling General And Administration: 86618000.00
IMXI balance_sheet (annual, 2022-12-31) — Share Issued: 39453236.00
IMXI cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 76000000.00
IMXI income_statement (annual, 2022-12-31) — Special Income Charges: -3005000.00
IMXI cash_flow (annual, 2022-12-31) — Stock Based Compensation: 7118000.00
IMXI balance_sheet (annual, 2022-12-31) — Stockholders Equity: 149906000.00
IMXI balance_sheet (annual, 2022-12-31) — Tangible Book Value: 80306000.00
IMXI income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -775679.55
IMXI income_statement (annual, 2022-12-31) — Tax Provision: 19948000.00
IMXI income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.26
IMXI balance_sheet (annual, 2022-12-31) — Total Assets: 512072000.00
IMXI balance_sheet (annual, 2022-12-31) — Total Capitalization: 300141000.00
IMXI balance_sheet (annual, 2022-12-31) — Total Debt: 183740000.00
IMXI balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 149906000.00
IMXI income_statement (annual, 2022-12-31) — Total Expenses: 460892000.00
IMXI balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 362166000.00
IMXI balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 129636000.00
IMXI balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 177399000.00
IMXI income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 82908000.00
IMXI balance_sheet (annual, 2022-12-31) — Total Tax Payable: 1329000.00
IMXI income_statement (annual, 2022-12-31) — Total Unusual Items: -3005000.00
IMXI income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -3005000.00
IMXI balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 2822266.00
IMXI balance_sheet (annual, 2022-12-31) — Treasury Stock: 59300000.00
IMXI balance_sheet (annual, 2022-12-31) — Working Capital: 197669000.00
IMXI income_statement (annual, 2023-12-31) — +Operating Expense: 130721000.00
IMXI income_statement (annual, 2023-12-31) — +Total Revenue: 658735000.00
IMXI balance_sheet (annual, 2023-12-31) — Accounts Payable: 36507000.00
IMXI balance_sheet (annual, 2023-12-31) — Accounts Receivable: 155237000.00
IMXI balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -46083000.00
IMXI balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 75686000.00
IMXI balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -2610000.00
IMXI cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
IMXI income_statement (annual, 2023-12-31) — Basic Average Shares: 35604582.00
IMXI income_statement (annual, 2023-12-31) — Basic EPS: 1.67
IMXI cash_flow (annual, 2023-12-31) — Beginning Cash Position: 149493000.00
IMXI balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 663000.00
IMXI cash_flow (annual, 2023-12-31) — Capital Expenditure: -12803000.00
IMXI balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 27625000.00
IMXI balance_sheet (annual, 2023-12-31) — Capital Stock: 4000.00
IMXI balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 239203000.00
IMXI balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 239203000.00
IMXI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -37120000.00
IMXI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -18280000.00
IMXI cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 143525000.00
IMXI cash_flow (annual, 2023-12-31) — Change In Account Payable: 20636000.00
IMXI cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -6235000.00
IMXI cash_flow (annual, 2023-12-31) — Change In Payable: 24623000.00
IMXI cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 24623000.00
IMXI cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 61514000.00
IMXI cash_flow (annual, 2023-12-31) — Change In Receivables: -29243000.00
IMXI cash_flow (annual, 2023-12-31) — Change In Working Capital: 50659000.00
IMXI cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -29243000.00
IMXI cash_flow (annual, 2023-12-31) — Changes In Cash: 88125000.00
IMXI balance_sheet (annual, 2023-12-31) — Common Stock: 4000.00
IMXI balance_sheet (annual, 2023-12-31) — Common Stock Equity: 149037000.00
IMXI cash_flow (annual, 2023-12-31) — Common Stock Payments: -66264000.00
IMXI balance_sheet (annual, 2023-12-31) — Construction In Progress: 6358000.00
IMXI income_statement (annual, 2023-12-31) — Cost Of Revenue: 430865000.00
IMXI balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 14447000.00
IMXI balance_sheet (annual, 2023-12-31) — Current Assets: 432874000.00
IMXI balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 4955000.00
IMXI balance_sheet (annual, 2023-12-31) — Current Debt: 7163000.00
IMXI balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 12118000.00
IMXI balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 4771000.00
IMXI balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 4771000.00
IMXI balance_sheet (annual, 2023-12-31) — Current Liabilities: 223373000.00
IMXI cash_flow (annual, 2023-12-31) — Deferred Income Tax: -2623000.00
IMXI cash_flow (annual, 2023-12-31) — Deferred Tax: -2623000.00
IMXI cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 12866000.00
IMXI income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 12866000.00
IMXI cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 12866000.00
IMXI income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 12866000.00
IMXI income_statement (annual, 2023-12-31) — Diluted Average Shares: 36429714.00
IMXI income_statement (annual, 2023-12-31) — Diluted EPS: 1.63
IMXI income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 59515000.00
IMXI income_statement (annual, 2023-12-31) — EBIT: 95490000.00
IMXI income_statement (annual, 2023-12-31) — EBITDA: 108356000.00
IMXI cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 1585000.00
IMXI cash_flow (annual, 2023-12-31) — End Cash Position: 239203000.00
IMXI cash_flow (annual, 2023-12-31) — Financing Cash Flow: -37120000.00
IMXI cash_flow (annual, 2023-12-31) — Free Cash Flow: 130722000.00
IMXI cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 1785000.00
IMXI balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 262000.00
IMXI income_statement (annual, 2023-12-31) — General And Administrative Expense: 112858000.00
IMXI balance_sheet (annual, 2023-12-31) — Goodwill: 53986000.00
IMXI balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 72129000.00
IMXI balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 157847000.00
IMXI balance_sheet (annual, 2023-12-31) — Gross PPE: 106197000.00
IMXI income_statement (annual, 2023-12-31) — Gross Profit: 227870000.00
IMXI cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 21503000.00
IMXI income_statement (annual, 2023-12-31) — Interest Expense: 10426000.00
IMXI income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 10426000.00
IMXI cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 9180000.00
IMXI balance_sheet (annual, 2023-12-31) — Invested Capital: 337273000.00
IMXI cash_flow (annual, 2023-12-31) — Investing Cash Flow: -18280000.00
IMXI cash_flow (annual, 2023-12-31) — Issuance Of Debt: 38000000.00
IMXI balance_sheet (annual, 2023-12-31) — Land And Improvements: 36000.00
IMXI balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 22670000.00
IMXI balance_sheet (annual, 2023-12-31) — Long Term Debt: 181073000.00
IMXI balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 203743000.00
IMXI cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 38000000.00
IMXI cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -5469000.00
IMXI balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 67040000.00
IMXI cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -5477000.00
IMXI cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -66264000.00
IMXI income_statement (annual, 2023-12-31) — Net Income: 59515000.00
IMXI income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 59515000.00
IMXI income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 59515000.00
IMXI income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 59515000.00
IMXI income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 59515000.00
IMXI cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 59515000.00
IMXI income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 59515000.00
IMXI income_statement (annual, 2023-12-31) — Net Interest Income: -10426000.00
IMXI cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: 0.00
IMXI cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 32531000.00
IMXI cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 32531000.00
IMXI income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -10426000.00
IMXI cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -4685000.00
IMXI balance_sheet (annual, 2023-12-31) — Net PPE: 60114000.00
IMXI cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -12803000.00
IMXI balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 76908000.00
IMXI balance_sheet (annual, 2023-12-31) — Non Current Accounts Receivable: 2897000.00
IMXI balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 659000.00
IMXI balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 659000.00
IMXI balance_sheet (annual, 2023-12-31) — Non Current Prepaid Assets: 3372000.00
IMXI income_statement (annual, 2023-12-31) — Normalized EBITDA: 110015000.00
IMXI income_statement (annual, 2023-12-31) — Normalized Income: 60675718.81
IMXI cash_flow (annual, 2023-12-31) — Operating Cash Flow: 143525000.00
IMXI cash_flow (annual, 2023-12-31) — Operating Gains Losses: 1785000.00
IMXI income_statement (annual, 2023-12-31) — Operating Income: 97149000.00
IMXI income_statement (annual, 2023-12-31) — Operating Revenue: 649448000.00
IMXI balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 33823237.00
IMXI balance_sheet (annual, 2023-12-31) — Other Current Assets: 2611000.00
IMXI balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 7163000.00
IMXI balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 2002000.00
IMXI balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 262000.00
IMXI income_statement (annual, 2023-12-31) — Other Gand A: 42655000.00
IMXI income_statement (annual, 2023-12-31) — Other Income Expense: -1659000.00
IMXI balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 18143000.00
IMXI cash_flow (annual, 2023-12-31) — Other Non Cash Items: 8215000.00
IMXI balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 5426000.00
IMXI income_statement (annual, 2023-12-31) — Other Operating Expenses: -9287000.00
IMXI balance_sheet (annual, 2023-12-31) — Other Payable: 144915000.00
IMXI balance_sheet (annual, 2023-12-31) — Other Properties: 32100000.00
IMXI balance_sheet (annual, 2023-12-31) — Other Receivables: 1514000.00
IMXI balance_sheet (annual, 2023-12-31) — Payables: 190035000.00
IMXI balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 204482000.00
IMXI balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
IMXI balance_sheet (annual, 2023-12-31) — Prepaid Assets: 34309000.00
IMXI income_statement (annual, 2023-12-31) — Pretax Income: 85064000.00
IMXI cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 1298000.00
IMXI balance_sheet (annual, 2023-12-31) — Properties: 0.00
IMXI income_statement (annual, 2023-12-31) — Provision For Doubtful Accounts: 4997000.00
IMXI cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 4997000.00
IMXI cash_flow (annual, 2023-12-31) — Purchase Of Business: -5477000.00
IMXI cash_flow (annual, 2023-12-31) — Purchase Of PPE: -12803000.00
IMXI balance_sheet (annual, 2023-12-31) — Receivables: 156751000.00
IMXI income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 430865000.00
IMXI income_statement (annual, 2023-12-31) — Reconciled Depreciation: 12866000.00
IMXI cash_flow (annual, 2023-12-31) — Repayment Of Debt: -5469000.00
IMXI cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -66264000.00
IMXI income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 1659000.00
IMXI balance_sheet (annual, 2023-12-31) — Retained Earnings: 198649000.00
IMXI income_statement (annual, 2023-12-31) — Salaries And Wages: 70203000.00
IMXI cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 0.00
IMXI income_statement (annual, 2023-12-31) — Selling General And Administration: 112858000.00
IMXI balance_sheet (annual, 2023-12-31) — Share Issued: 39673271.00
IMXI income_statement (annual, 2023-12-31) — Special Income Charges: -1659000.00
IMXI cash_flow (annual, 2023-12-31) — Stock Based Compensation: 8111000.00
IMXI balance_sheet (annual, 2023-12-31) — Stockholders Equity: 149037000.00
IMXI balance_sheet (annual, 2023-12-31) — Tangible Book Value: 76908000.00
IMXI income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -498281.19
IMXI income_statement (annual, 2023-12-31) — Tax Provision: 25549000.00
IMXI income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.30
IMXI balance_sheet (annual, 2023-12-31) — Total Assets: 576812000.00
IMXI balance_sheet (annual, 2023-12-31) — Total Capitalization: 330110000.00
IMXI balance_sheet (annual, 2023-12-31) — Total Debt: 215861000.00
IMXI balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 149037000.00
IMXI income_statement (annual, 2023-12-31) — Total Expenses: 561586000.00
IMXI balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 427775000.00
IMXI balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 143938000.00
IMXI balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 204402000.00
IMXI income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 95490000.00
IMXI balance_sheet (annual, 2023-12-31) — Total Tax Payable: 8613000.00
IMXI income_statement (annual, 2023-12-31) — Total Unusual Items: -1659000.00
IMXI income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -1659000.00
IMXI balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 5850034.00
IMXI balance_sheet (annual, 2023-12-31) — Treasury Stock: 125564000.00
IMXI balance_sheet (annual, 2023-12-31) — Working Capital: 209501000.00
IMXI balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 0.00
IMXI cash_flow (quarterly, 2024-09-30) — Net Business Purchase And Sale: -1799000.00
IMXI cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: -1800000.00
IMXI balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Assets: 451000.00
IMXI balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 451000.00
IMXI cash_flow (quarterly, 2024-09-30) — Purchase Of Business: -1799000.00
IMXI cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 910450000.00
IMXI income_statement (annual, 2024-12-31) — +Operating Expense: 129786000.00
IMXI income_statement (annual, 2024-12-31) — +Total Revenue: 658649000.00
IMXI balance_sheet (annual, 2024-12-31) — Accounts Payable: 19520000.00
IMXI balance_sheet (annual, 2024-12-31) — Accounts Receivable: 107077000.00
IMXI balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -58068000.00
IMXI balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 79592000.00
IMXI balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -3546000.00
IMXI cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
IMXI income_statement (annual, 2024-12-31) — Basic Average Shares: 32430755.00
IMXI income_statement (quarterly, 2024-12-31) — Basic Average Shares: 30998252.00
IMXI income_statement (annual, 2024-12-31) — Basic EPS: 1.81
IMXI income_statement (quarterly, 2024-12-31) — Basic EPS: 0.50
IMXI cash_flow (annual, 2024-12-31) — Beginning Cash Position: 239203000.00
IMXI balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 658000.00
IMXI balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 658000.00
IMXI cash_flow (annual, 2024-12-31) — Capital Expenditure: -29997000.00
IMXI balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 25050000.00
IMXI balance_sheet (annual, 2024-12-31) — Capital Stock: 4000.00
IMXI balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 130503000.00
IMXI balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 130503000.00
IMXI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -114204000.00
IMXI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -43946000.00
IMXI cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 53085000.00
IMXI cash_flow (annual, 2024-12-31) — Change In Account Payable: -23125000.00
IMXI cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -5852000.00
IMXI cash_flow (annual, 2024-12-31) — Change In Payable: -59405000.00
IMXI cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -59405000.00
IMXI cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -18764000.00
IMXI cash_flow (annual, 2024-12-31) — Change In Receivables: 41598000.00
IMXI cash_flow (annual, 2024-12-31) — Change In Working Capital: -42423000.00
IMXI cash_flow (annual, 2024-12-31) — Changes In Account Receivables: 41598000.00
IMXI cash_flow (annual, 2024-12-31) — Changes In Cash: -105065000.00
IMXI balance_sheet (annual, 2024-12-31) — Common Stock: 4000.00
IMXI balance_sheet (annual, 2024-12-31) — Common Stock Equity: 134924000.00
IMXI cash_flow (annual, 2024-12-31) — Common Stock Payments: -75132000.00
IMXI balance_sheet (annual, 2024-12-31) — Construction In Progress: 0.00
IMXI balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 0.00
IMXI income_statement (annual, 2024-12-31) — Cost Of Revenue: 428968000.00
IMXI balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 14827000.00
IMXI balance_sheet (annual, 2024-12-31) — Current Assets: 297783000.00
IMXI balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 6468000.00
IMXI balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 6468000.00
IMXI balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 2692000.00
IMXI balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 2692000.00
IMXI balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 2692000.00
IMXI balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 2692000.00
IMXI balance_sheet (annual, 2024-12-31) — Current Liabilities: 151998000.00
IMXI cash_flow (annual, 2024-12-31) — Deferred Income Tax: -448000.00
IMXI cash_flow (annual, 2024-12-31) — Deferred Tax: -448000.00
IMXI cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 13645000.00
IMXI income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 13645000.00
IMXI cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 13645000.00
IMXI income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 13645000.00
IMXI income_statement (annual, 2024-12-31) — Diluted Average Shares: 32850497.00